Research on the Application of Artificial Intelligence 
Technology in Drug Development

Douqiu Liu

doi:10.70711/mhr.v2i3.4915

Research on the Application of Artificial Intelligence Technology in Drug Development

Douqiu Liu

Abstract

Artificial intelligence (AI) has made significant progress in drug research and development in recent years. This paper reviews relevant literature from the past five years and discusses the applications and future development trends of AI in the four major steps of drugs.
The discovery of drugs, preclinical research, clinical trials, and drug approval and marketing.
It shows the innovations and efficiency improvements of AI techniques at each stage.

Keywords

Drug discovery; Artificial intelligence; Target identification; Deep learning; Toxicity prediction

Full Text:

PDF

Included Database

References

[1] Jumper J, Evans R, Pritzel A, et al. Highly accurate protein structure prediction with AlphaFold[J]. Nature. 2021;596(7873):583-589.

[2] Narain N, Kiebish M, Vishnudas V, et al. CSAO-1. Interrogative Biology: Unraveling insights into causal disease drivers by use of a

dynamic systems biology and Bayesian AI to identify the intersect of disease and healthy signatures[J]. Neuro-Oncology Advances.

2021;3(Supplement_2):ii1.

[3] Wang C, Xiao F, Li MZ, et al. Progress in the application of artificial intelligence in screening and validation of drug targets[J]. J China

Pharm Univ. 2023;54(3):269-281.

[4] Richardson P, Griffin I, Tucker C, et al. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease[J]. Lancet.

2020;395(10223):e30-e31.

[5] Wan F, Zhu Y, Hu H, et al. DeepCPI: A Deep Learning-based Framework for Large-scale in silico Drug Screening[J]. Genomics Proteomics Bioinformatics. 2019;17(5):478-495.

[6] Liu XQ, Zhu YJ, Feng DW, et al. Screening and activity evaluation of SMYD2 inhibitors based on deep learning[J]. Journal of Yantai

University (Natural Science and Engineering Edition).:1-11.

[7] Ding BX, Hu J, Wang JF. Progress in the application of artificial intelligence in drug discovery and development[J]. Shandong Chemical

Industry. 2019;48(22):70-73.

[8] Chou WC, Lin Z. Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling[J]. Toxicol Sci.

2023;191(1):1-14.

[9] Wang D, Liu W, Shen Z, et al. Deep Learning Based Drug Metabolites Prediction[J]. Front Pharmacol. 2019;10:1586.

[10] Lind AP, Anderson PC. Predicting drug activity against cancer cells by random forest models based on minimal genomic information

and chemical properties[J]. PLoS One. 2019;14(7):e0219774.

[11] Mayr A, Klambauer G, Unterthiner T, Hochreiter S. DeepTox: Toxicity Prediction using Deep Learning[J]. Front Environ Sci. 2016;3.

[12] Savage N. Tapping into the drug discovery potential of AI[J]. Biopharma Dealmakers. Published online May 27, 2021.

[13] Topol EJ. High-performance medicine: the convergence of human and artificial intelligence[J]. Nat Med. 2019;25(1):44-56.

[14] Esteva A, Robicquet A, Ramsundar B, et al. A guide to deep learning in healthcare[J]. Nat Med. 2019;25(1):24-29.

[15] Mak KK, Pichika MR. Artificial intelligence in drug development: present status and future prospects[J]. Drug Discov Today.

2019;24(3):773-780.

DOI: http://dx.doi.org/10.70711/mhr.v2i3.4915

Refbacks

There are currently no refbacks.